India, Dec. 11 -- Dr. Reddy's Laboratories Ltd. (RDY,DRREDDY) announced Friday the launch of Deferasirox Film-Coated Tablets, 90 mg and 360 mg. It is a therapeutically equivalent generic version of Jadenu (deferasirox) Film-Coated Tablets, 90 mg, 180 mg, and 360 mg, approved by the U.S. Food and Drug Administration.
The Jadenu brand had U.S. sales of approximately $470 million for the most recent twelve months ended in September 2019.
The company also announced the launch of Deferasirox Tablets for Oral Suspension, a therapeutically equivalent generic version of Exjade (deferasirox) Tablets for Oral Suspension, approved by the FDA.
The Exjade brand had U.S. sales of approximately $113 million in a year ended September 2019.
Dr. Reddy's ...